Zyban Withdrawal and Tapering Help
Zyban (Wellbutrin) is a psychostimulant that can also cause an antidepressant discontinuation syndrome although it affects dopamine, norepinephrine and GABA. Our NonProfit has been helping people withdraw safely for 15 Years. Contact Us
if you need help weaning off Zyban.
How the Program and Tapering Process Works Zyban Dependence
Our Zyban weaning program is a slow taper that allows you to safely step down from Zyban under the guidance of our Prescription Experts; your Physician and Pharmacist.
The Pre-Taper is for Symptom Relief. You will not wean Zyban until you feel better. This is where our Advanced Nutraceuticals are critical.
Point of Return provides healthy, Drug-Free Strategies to help minimize Zyban withdrawal symptoms to improve mental and physical well-being.
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis.
At-Home programs are individualized based on your situation. An assessment is done once you start which allows us to individualize your gameplan based on age; length of time on the medications; health challenges; lifestyle, stress levels; additional medications; and interactions. Don't Wean Zyban alone, work with our Prescription Drug Experts.
Imagine being Free of Zyban Addiction
- Proven Program completed At-Home with Expert Guidance
- Our secret is a Slow Taper combined with Powerful all-natural
Nutraceuticals to help ease Zyban withdrawal symptoms
- Your program is customized for your specific situation
- Professional information on interactions
- 15 years of experience helping people in 78 countries
- Free Expert Mentoring on our 24/7 private Discussion Board
- Free Assessment Upon Starting our Program (a $400 value)
Learn More about how our process works.
Some people have paid the ultimate price suffering and labeled when all along it was what we know as withdrawal syndrome. I am one of the survivors. For this I am grateful beyond words can truly express! more...by Mike E. (Missouri, USA)
Break Free Today
At Point of Return, a 501(c)3 nonprofit, we have spent the last 15 years helping people taper off Zyban correctly. With customized taper rates and all natural nutraceuticals, our program allows you to come off Zyban, once and for all, from the comfort of your home.
Read program FAQ page.
" Before I came to Point of Return, I had tried to get off antidepressants on my own a few times. Each time I was fine for a while, but then some life change would hit and I would be back on them again. I
am now free from drugs thanks to this program, and look forward to paying it forward and helping others in their journey to loving themselves once again. - Paula V.
reach out for help
Zyban history and info
Zyban is an atypical antidepressant that acts on Norepinephrine and Dopamine and belongs to the chemical class of aminoketones that are similar in structure to amphetamines. Zyban is a psychostimulant that exerts its action on Dopamine and Norepinephrine. Dopamine performs a key role in the brain system’s reward-driven learning, and Norepinephrine is crucial in the fight-or-flight response by triggering the release of glucose, increasing heart rate and blood flow to the skeletal system. While the prescribing information for Zyban states a gradual taper is not necessary, 30% of patients have shown withdrawal symptoms do occur that include anxiety, irritability, aggression, mania, uncontrolled movements and mania. Abruptly or rapidly stopping Zyban is not recommended due to the withdrawal syndrome. A gradual taper is advise.
Zyban was unsuccessfully marketed as an antidepressant but was found to be effective as a smoking cessation aid. By 2006 it was the fourth-most prescribed antidepressant in the United States.
Wellbutrin (Zyban) was released in 1986 with dosage recommendations of 400-600mg, however a significant incidence of seizures caused the drug to be removed the same year. Wellbutrin (Zyban) was reintroduced in 1989 with a maximum recommended dose of 450mg/day. The FDA approved the sustained-release formulation in 1996 called Wellbutrin SR that required twice a day dosing. In 2003 the FDA approved another sustained release formulation called Wellbutrin XL that called for once a day dosing. GlaxoSmithKline Pharmaceuticals advises that Wellubtin (Zyban) should not be prescribed to patients with epilepsy or other conditions that lower the seizure threshold.
There is evidence of neuropsychiatric symptoms associated with Zyban (Wellbutrin) in patients with depression, including hallucinations, psychosis, delusions, paranoia, confusion and disturbances in concentration. These side effects
are also common with stimulant medications. In addition, the prescribing information lists hypertension, sometimes severe, was observed in patients both with and without pre-existing hypertension. There have been reports of
a false-positive urine test for amphetamine use in persons taking Wellbutrin (Bupropion).
According to the FDA:
General: Agitation and Insomnia: A substantial proportion of patients treated with WELLBUTRIN experience some degree of increased restlessness, agitation, anxiety, and insomnia, especially shortly after initiation of treatment. In clinical studies, these symptoms were sometimes of sufficient magnitude to require treatment with sedative/hypnotic drugs. In approximately 2% of patients, symptoms were sufficiently severe to require discontinuation of treatment with WELLBUTRIN.
Psychosis, Confusion, and Other Neuropsychiatric Phenomena: Depressed patients treated with WELLBUTRIN have been reported to show a variety of neuropsychiatric signs and symptoms including delusions, hallucinations, psychosis, concentration disturbance, paranoia, and confusion. Because of the uncontrolled nature of many studies, it is impossible to provide a precise estimate of the extent of risk imposed by treatment with WELLBUTRIN. In several cases, neuropsychiatric phenomena abated upon dose reduction and/or withdrawal of treatment.
Activation of Psychosis and/or Mania: Antidepressants can precipitate manic episodes in bipolar disorder patients during the depressed phase of their illness and may activate latent psychosis in other susceptible patients. WELLBUTRIN is expected to pose similar risks.
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with your physician to help you with your drug withdrawal process and with his or her consent.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More...